The Israeli Ministry of Health, Pfizer and BioNTech said on Thursday that data from Israel’s national vaccination campaign demonstrates that their vaccine is 94 percent effective in preventing asymptomatic infections.

They also said that Israeli data shows that vaccinations prevented symptomatic disease, severe cases and death with 97 percent effectiveness, according to a statement released by the companies and the Health Ministry.

More than 5 million Israelis, or about 55 percent of its population of 9 million people, have received the first shot of the vaccine, and nearly 4 four million, or 43 percent, have gotten the second shot.

The analysis was derived from data collected by Israel’s Health Ministry from Jan. 17 until March 6.

“Israel’s strong health system and an unprecedented societal mobilization and awareness allowed us to achieve high national uptake of the COVID-19 vaccine in a short period of time. Thanks to our comprehensive public-health surveillance program, we have been able to document the remarkable success of the nationwide vaccination campaign with the COVID-19 vaccine,” said Professor Yeheskel Levy, director of Israel’s Ministry of Health.

He added: “Incidence rates in the fully vaccinated population have massively dropped compared to the unvaccinated population, showing a marked decline in hospitalized cases due to COVID-19.”

JNS

Support
Jewish News Syndicate


With geographic, political and social divides growing wider, high-quality reporting and informed analysis are more important than ever to keep people connected.

Our ability to cover the most important issues in Israel and throughout the Jewish world—without the standard media bias—depends on the support of committed readers.

If you appreciate the value of our news service and recognize how JNS stands out among the competition, please click on the link and make a one-time or monthly contribution.

We appreciate your support.